1PBH | A:1-250 | CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION |
3K9M | B:1-250; B:1-250 | CATHEPSIN B IN COMPLEX WITH STEFIN A |
3PBH | A:1-250 | REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION |
1K3B | C:371-434; C:371-434 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C): EXCLUSION DOMAIN ADDED TO AN ENDOPEPTIDASE FRAMEWORK CREATES THE MACHINE FOR ACTIVATION OF GRANULAR SERINE PROTEASES |
1M6D | B:1-210; B:1-210 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN F |
1MEM | A:1-210 | CRYSTAL STRUCTURE OF CATHEPSIN K COMPLEXED WITH A POTENT VINYL SULFONE INHIBITOR |
1NL6 | B:1-214; B:1-214 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR |
1NLJ | B:1-214; B:1-214 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR |
1Q6K | A:1-214 | CATHEPSIN K COMPLEXED WITH T-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE |
1SNK | A:2-214 | CATHEPSIN K COMPLEXED WITH CARBAMATE DERIVATIZED NORLEUCINE ALDEHYDE |
1TU6 | B:115-328; B:115-328 | CATHEPSIN K COMPLEXED WITH A KETOAMIDE INHIBITOR |
1U9V | A:1-214 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABE854 |
1U9W | A:1-214 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABI491 |
1U9X | A:1-214 | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR NVP-ABJ688 |
1VSN | A:1-210 | CRYSTAL STRUCTURE OF A POTENT SMALL MOLECULE INHIBITOR BOUND TO CATHEPSIN K |
1YK7 | A:1-214 | CATHEPSIN K COMPLEXED WITH A CYANOPYRROLIDINE INHIBITOR |
1YK8 | A:117-328 | CATHEPSIN K COMPLEXED WITH A CYANAMIDE-BASED INHIBITOR |
1YT7 | A:2-214 | CATHEPSIN K COMPLEXED WITH A CONSTRAINED KETOAMIDE INHIBITOR |
2R6N | A:1-214 | CRYSTAL STRUCTURE OF A PYRROLOPYRIMIDINE INHIBITOR IN COMPLEX WITH HUMAN CATHEPSIN K |
3KW9 | A:1-214 | X-RAY STRUCTURE OF CATHEPSIN K COVALENTLY BOUND TO A TRIAZINE LIGAND |
3KWB | Y:2006-2214; Y:2006-2214 | STRUCTURE OF CATK COVALENTLY BOUND TO A DIOXO-TRIAZINE INHIBITOR |
3KWZ | A:1-214 | CATHEPSIN K IN COMPLEX WITH A NON-SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR |
3KX1 | A:3-214 | CATHEPSIN K IN COMPLEX WITH A SELECTIVE 2-CYANO-PYRIMIDINE INHIBITOR |
3O0U | A:1-214 | CATHEPSIN K COVALENTLY BOUND TO A CYANO-PYRIMIDINE INHIBITOR WITH IMPROVED SELECTIVITY OVER HERG |
3O1G | A:1-214 | CATHEPSIN K COVALENTLY BOUND TO A 2-CYANO PYRIMIDINE INHIBITOR WITH A BENZYL P3 GROUP. |
2NQD | B:1-219 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE INHIBITOR, CHAGASIN, IN COMPLEX WITH HUMAN CATHEPSIN L |
2VHS | D:1-219; D:1-219; D:1-219; D:1-219 | CATHSILICATEIN, A CHIMERA |
2XU1 | D:1-219; D:1-219; D:1-219; D:1-219 | CATHEPSIN L WITH A NITRILE INHIBITOR |
2XU3 | A:1-219 | CATHEPSIN L WITH A NITRILE INHIBITOR |
2XU4 | A:1-219 | CATHEPSIN L WITH A NITRILE INHIBITOR |
2XU5 | A:1-219 | CATHEPSIN L WITH A NITRILE INHIBITOR |
3K24 | B:1-219; B:1-219 | CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE |
3OF8 | A:2-220 | STRUCTURAL BASIS FOR REVERSIBLE AND IRREVERSIBLE INHIBITION OF HUMAN CATHEPSIN L BY THEIR RESPECTIVE DIPEPTIDYL GLYOXAL AND DIAZOMETHYLKETONE INHIBITORS |
3OF9 | A:2-220 | STRUCTURAL BASIS FOR IRREVERSIBLE INHIBITION OF HUMAN CATHEPSIN L BY A DIAZOMETHYLKETONE INHIBITOR |
3KFQ | B:1-220; B:1-220 | UNREDUCED CATHEPSIN V IN COMPLEX WITH STEFIN A |
1MS6 | A:1-216 | DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S. |
1NPZ | B:251-466; B:251-466 | CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES |
2OP3 | B:1-216; B:1-216 | THE STRUCTURE OF CATHEPSIN S WITH A NOVEL 2-ARYLPHENOXYACETALDEHYDE INHIBITOR DERIVED BY THE SUBSTRATE ACTIVITY SCREENING (SAS) METHOD |
2R9M | B:1-216; B:1-216 | CATHEPSIN S COMPLEXED WITH COMPOUND 15 |
2R9N | B:1-216; B:1-216 | CATHEPSIN S COMPLEXED WITH COMPOUND 26 |
2R9O | B:1-216; B:1-216 | CATHEPSIN S COMPLEXED WITH COMPOUND 8 |
3KWN | B:1-216; B:1-216 | CATHEPSIN S IN COMPLEX WITH THIOETHER ACETAMIDE P3 INHIBITOR |
3MPE | B:1-216; B:1-216 | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S C25S MUTANT WITH BOUND DRUG |
3N3G | B:1-216; B:1-216 | 4-(3-TRIFLUOROMETHYLPHENYL)-PYRIMIDINE-2-CARBONITRILE AS CATHEPSIN S INHIBITORS: N3, NOT N1 IS CRITICALLY IMPORTANT |
3N4C | B:1-216; B:1-216 | 6-PHENYL-1H-IMIDAZO[4,5-C]PYRIDINE-4-CARBONITRILE AS CATHEPSIN S INHIBITORS |